Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Inventory Average (2016 - 2025)

Trinity Biotech's Inventory Average history spans 17 years, with the latest figure at $19.5 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 5.39% to $19.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.5 million, a 5.39% decrease, with the full-year FY2025 number at $19.1 million, up 86.04% from a year prior.
  • Inventory Average hit $19.5 million in Q4 2025 for Trinity Biotech, down from $19.8 million in the prior quarter.
  • Over the last five years, Inventory Average for TRIB hit a ceiling of $36.1 million in Q2 2021 and a floor of $11.0 million in Q4 2023.
  • Historically, Inventory Average has averaged $24.2 million across 5 years, with a median of $22.6 million in 2024.
  • Biggest five-year swings in Inventory Average: crashed 52.15% in 2023 and later skyrocketed 86.83% in 2024.
  • Tracing TRIB's Inventory Average over 5 years: stood at $30.6 million in 2021, then decreased by 24.79% to $23.0 million in 2022, then crashed by 52.15% to $11.0 million in 2023, then surged by 86.83% to $20.6 million in 2024, then dropped by 5.39% to $19.5 million in 2025.
  • Business Quant data shows Inventory Average for TRIB at $19.5 million in Q4 2025, $19.8 million in Q2 2025, and $20.6 million in Q4 2024.